Samsung's venture investment unit is reportedly looking to invest up to $100 million in Exo, a California-based medical device startup that specializes in handheld ultrasound technology. Led by Sands Capital, Bold Capital, and Qubit Health Capital, this funding could enhance Exo's capabilities, which combine artificial intelligence with medical imaging for convenient examinations. Founded in 2015, Exo has raised over $320 million from prominent investors and is exploring partnerships with Samsung Medison, a firm known for ultrasound diagnostics. With advanced technology, Exo presents a significant opportunity in the medical imaging field.
Samsung's investment unit targets a $100 million stake in Exo, a startup revolutionizing medical imaging with AI and smartphone integration, ideal for ultrasound examinations.
Exo, founded in 2015, combines AI and silicon technology in handheld ultrasound devices, significantly enhancing how medical exams can be conducted and managed.
With over $320 million raised since its inception and a notable partnership in discussions with Samsung Medison, Exo is poised for growth.
The recent investment round led by firms like Sands Capital signifies strong confidence in Exo's innovative approach to medical imaging in a mobile format.
Collection
[
|
...
]